Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
by Gomez-Mancilla, Baltazar (Author)
, Meriggioli, Matthew N. (Author)
, Genge, Angela (Author)
, Roubenoff, Ronenn (Author)
, Espié, Pascal (Author)
, Dupuy, Cyrielle (Author)
, Hartmann, Nicole (Author)
, Pezous, Nicole (Author)
, Kinhikar, Arvind (Author)
, Tichy, Mia (Author)
, Dionne, Annie (Author)
, Vissing, John (Author)
, Andersen, Henning (Author)
, Schoser, Benedikt (Author)
, Meisel, Andreas (Author)
, Devlikamova, Farida (Author)
, Poverennova, Irina (Author)
, Stuchevskaya, Fatima (Author)
, Lin, Thy-Sheng (Author)
, Rush, James S. (Author)
, Gergely, Peter (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource